Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Guidance for Industry
FDA-2022-D-0112-0014Other
Comments
1
Last activity Jul 27, 2026
Deadline
--
Net supportiSupport minus oppose · campaigns included
+100%
+100% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development; Guidance for Industry
- Posted
- Oct 18, 2024
- Comment period
- Oct 18, 2024 – ?
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
+100%
Net support
Support1
Aggregates include form-letter campaigns. Excluding them, net support is +100% across organic comments.
Who commented
Breakdown by commenter type.
Individual
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Oct 18, 2024
Jul 27
Support1Oppose0Other0
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Issues are identified as comment analysis progresses — nothing tagged on this document yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.